Aktive Positionen von Gregory W. Gin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EVC Group, Inc. | Corporate Officer/Principal | - | - |
Karriereverlauf von Gregory W. Gin
Ehemalige bekannte Positionen von Gregory W. Gin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Investor Relations Kontakt | 01.07.2016 | - |
AFFIMED N.V. | Investor Relations Kontakt | 01.06.2018 | - |
Public Communications Contact | 01.06.2018 | - | |
Genta, Inc.
Genta, Inc. Pharmaceuticals: MajorHealth Technology Genta, Inc. is in the process of bankruptcy. The company formerly engages in pharmaceutical research and development. Genta was founded on February 4, 1988 and is headquartered in Berkeley Heights, NJ. | Public Communications Contact | - | - |
Statistik
International
Vereinigte Staaten | 4 |
Deutschland | 2 |
Operativ
Public Communications Contact | 2 |
Investor Relations Contact | 2 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AFFIMED N.V. | Health Technology |
Private Unternehmen | 3 |
---|---|
Genta, Inc.
Genta, Inc. Pharmaceuticals: MajorHealth Technology Genta, Inc. is in the process of bankruptcy. The company formerly engages in pharmaceutical research and development. Genta was founded on February 4, 1988 and is headquartered in Berkeley Heights, NJ. | Health Technology |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
EVC Group, Inc. |
- Börse
- Insiders
- Gregory W. Gin
- Erfahrung